1. Home
  2. LXEO vs OPP Comparison

LXEO vs OPP Comparison

Compare LXEO & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • OPP
  • Stock Information
  • Founded
  • LXEO 2017
  • OPP 2010
  • Country
  • LXEO United States
  • OPP United States
  • Employees
  • LXEO N/A
  • OPP N/A
  • Industry
  • LXEO
  • OPP Finance/Investors Services
  • Sector
  • LXEO
  • OPP Finance
  • Exchange
  • LXEO Nasdaq
  • OPP Nasdaq
  • Market Cap
  • LXEO 257.0M
  • OPP 208.6M
  • IPO Year
  • LXEO 2023
  • OPP N/A
  • Fundamental
  • Price
  • LXEO $5.10
  • OPP $8.77
  • Analyst Decision
  • LXEO Strong Buy
  • OPP
  • Analyst Count
  • LXEO 7
  • OPP 0
  • Target Price
  • LXEO $15.29
  • OPP N/A
  • AVG Volume (30 Days)
  • LXEO 388.3K
  • OPP 108.0K
  • Earning Date
  • LXEO 08-14-2025
  • OPP 01-01-0001
  • Dividend Yield
  • LXEO N/A
  • OPP 14.41%
  • EPS Growth
  • LXEO N/A
  • OPP N/A
  • EPS
  • LXEO N/A
  • OPP N/A
  • Revenue
  • LXEO N/A
  • OPP N/A
  • Revenue This Year
  • LXEO N/A
  • OPP N/A
  • Revenue Next Year
  • LXEO N/A
  • OPP N/A
  • P/E Ratio
  • LXEO N/A
  • OPP N/A
  • Revenue Growth
  • LXEO N/A
  • OPP N/A
  • 52 Week Low
  • LXEO $1.45
  • OPP $7.26
  • 52 Week High
  • LXEO $11.72
  • OPP $8.83
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 60.82
  • OPP 67.57
  • Support Level
  • LXEO $4.70
  • OPP $8.70
  • Resistance Level
  • LXEO $5.40
  • OPP $8.78
  • Average True Range (ATR)
  • LXEO 0.29
  • OPP 0.07
  • MACD
  • LXEO 0.01
  • OPP 0.01
  • Stochastic Oscillator
  • LXEO 69.38
  • OPP 91.07

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

Share on Social Networks: